Pharma & Biotech News #PharmaBuzz

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Weekly News Recap #Phispers

FDA clears path for uniQure's Huntington's filing; approves GSK-Spero's oral antibiotic for complicated UTIs

This week’s Phispers is loaded with news from the US Food and Drug Administration (FDA). The agency appears to be revisit...

Impressions : 1234

GSK acquires Nuvalent for US$ 10.6 bn to expand its oncology portfolio; Roche inks up to US$ 2.3 bn deal with Nurix

This week, Phispers brings you several developments in the field of oncology. One, GSK acquired a Boston-based clinical-stage b...

Impressions : 767

FDA approves Wockhardt's antibiotic for complicated UTIs; Pfizer inks up to US$ 10.5 billion deal with Innovent

This week’s Phispers is full of news about deals and clinical trials emerging out of the recently concluded annual meetin...

Impressions : 995

Lilly buys three vaccine drugmakers in deals worth up to US$ 3.8 bn; FDA approves AbbVie's ultra rare blood cancer drug

Buoyed by the rising sales of its obesity drug, Eli Lilly has been on an acquisition spree this year. The company announced ag...

Impressions : 1556

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

FDA clears path for uniQure's Huntington's filing; approves GSK-Spero's oral antibiotic for complicated UTIs

GSK acquires Nuvalent for US$ 10.6 bn to expand its oncology portfolio; Roche inks up to US$ 2.3 bn deal with Nurix

FDA approves Wockhardt's antibiotic for complicated UTIs; Pfizer inks up to US$ 10.5 billion deal with Innovent

Lilly buys three vaccine drugmakers in deals worth up to US$ 3.8 bn; FDA approves AbbVie's ultra rare blood cancer drug

Taro's Generics Perampanel Receives Approval in US

Saptalis Pharms' Generics Hydroxyzine HCl Receives Approval in US

Aurobindo's Generics Empagliflozin Receives Approval in US

Viwit Pharm's Generics Gadobutrol Receives Approval in US

Nephron's Generics Norepinephrine Receives Approval in US

Alembic's Generics Tretinoin Receives Approval in US

Alembic's Generics Vitrakvi Receives Tentative Approval in US

Pai's Generics Propranolol HCl Receives Approval in US

Apotex's Generics Ruxolitinib Receives Tentative Approval in US

Saptalis' Generics Tofacitinib Citrate Receives Approval in US

Enforcement Report - Week of June 17, 2026

Sante Manufacturing's Receives FDA Warning Letter

Beekeeper's Issues Voluntary Recall of Saline Nasal Spray

Erkul Kozmetik Sanayi ve Ticaret AS's Receives FDA Warning Letter

Asanuma Corporation Sagamihara's Receives FDA Warning Letter

Laboratorios Dr Collado S A's Receives FDA Warning Letter

Shantou Qiwei Industry's Receives FDA Warning Letter

Hubei Gedian Humanwell's Receives FDA Warning Letter

Zydus Lifesciences' Receives FDA Warning Letter

Gopaldas Visram's Receives FDA Warning Letter

Derm-Biome's DB-006 Outperforms Topicals in Eczema Preclinicals

Alvotech Raises $165M via Public Offering and Private Placement

bioAffinity Technologies Closes $3.2M Offering via WallachBeth

HPV vaccination drive reaches 50 lakh girls in three months

AbbVie Declares Quarterly Dividend

Cardio biotech Kardigan binds off $400M upsized IPO

Merck's pneumococcal vaccine wins US approval for high-risk child

Minaris Enhances GMP Cell Banking Suites at Philadelphia Facility

US FDA advisers Vote in Favor of Moderna's flu vaccine

Novocure Device Fails to Improve Brain Cancer Survival in Phase 3

Lupin Launches Azilsartan Medoxomil Tablets in the United States

FDA Approves First Generic Version Of Roche's Flu Drug

Glenmark Launches Generic Methylene Blue Injection In US Market

Kiran Mazumdar-Shaw Aims to Make Biocon Top Insulin Supplier

Dr Reddy's launches first-to-market generic Bosutinib in US

India Raises Price Cap on Cancer Drugs to Tackle Shortage

Cosmos Health Gets New Contract Orders for 253,657 Units

FDA OKs Emergency Use of OTC Drug for Screwworm in Pets

Astellas CEO's 5-Year Plan to Counter Xtandi Patent Cliff

Alembic Gets USFDA Tentative Approval for Larotrectinib ANDA

Derm-Biome's DB-006 Outperforms Topicals in Eczema Preclinicals

Alvotech Raises $165M via Public Offering and Private Placement

bioAffinity Technologies Closes $3.2M Offering via WallachBeth

HPV vaccination drive reaches 50 lakh girls in three months

Cardio biotech Kardigan binds off $400M upsized IPO

Merck's pneumococcal vaccine wins US approval for high-risk child

Minaris Enhances GMP Cell Banking Suites at Philadelphia Facility

US FDA advisers Vote in Favor of Moderna's flu vaccine

Oncoinvent Hits 50% Enrollment in Radspherin Ovarian Cancer Trial

Matica Biotech Launches Korea IIT Platform for Advanced Therapies

Ruixiang Launches Platinum-Cured Silicone Tubing for Medical OEMs

Neuland to set up $20m process development facility in Hyderabad

Symeres Expands Spray Drying Capabilities in New Jersey

Axplora consolidates global UDCA manufacturing at Vizag facility

Teva To Cut 250 Jobs At API Unit Amid Prolonged Owner Search

CBC India & Metalco-Alupack sign exclusive strategic partnership

TDB Supports Indigenous Production of Green Pharma Ingredients

PharmaBlock's First Peptide GMP Pilot Plant Now Operational

Niner Pharma Expands Global Peptide and Oncology API Network

Intracin Pharma Gets Australian APVMA Approval for Vet Medicines

WuXi Biologics' Suzhou Lab Wins Fourth EMA GMP Certification

FDA and EudraVigilance Dashboards Offer Lessons for India

Government prescribes end to OTC sale of cough syrups

FDA gives rejected drugs another chance in post-Makary era

FDA warns telehealth companies over compounded GLP-1s

India limits cough syrup sales to pharmacies after contamination

Longevity Health Earns Three 2026 PQA Awards for Medicare Quality

Expert: FDA's Real-Time CRL Release May Violate Law, Limit Talks

FDA Cites CGMP Failures, Flags Telehealth GLP-1 Marketing

MHRA Drug Safety Update: ACE-inhibitors

Novocure Device Fails to Improve Brain Cancer Survival in Phase 3

Treace Completes First Surgery with HyperPlate XM Implant System

Halberd Ships NeuroSense AI Update for Voice Behavior Monitoring